Login to Your Account

Eyes on Exicure: Reverse merger puts SNA technology before broader audience

By Marie Powers
News Editor

Monday, October 16, 2017

Considering that Chicago isn’t exactly a breeding ground for biopharma, Exicure Inc. already had defied expectations by raising more than $42 million since its inception in 2011 as Aurasense Therapeutics LLC and attracting the attention of tech and business notables such as Microsoft Corp. co-founder and philanthropist Bill Gates.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription